The solubilization of cytoskeletons of human erythrocyte membranes by p-mercuribenzene sulphonate.
The disruption of erythrocyte membrane cytoskeletons brought about by treatment with p-mercuribenzene sulphonate (PMBS) has been followed by measurements of turbidity and the binding of 203Hg-labelled PMBS. After pretreatment with N-ethylmaleimide to block readily reactive sulphydryl groups, incubation with [203Hg]PMBS showed incorporation of approximately 4 moles radiolabel per mole of spectrin and one per mole of actin. The incorporation of radiolabel paralleled the decrease in turbidity, and the labelling of spectrin paralleled that of actin. The kinetics were pseudo first order, and the pH dependence of the observed rate constant indicated a normal pKa value for the sulphydryl group involved. The calculated second-order rate constant for the reaction of the sulphydryl anion with PMBS, however, was several orders of magnitude less than expected from model compound studies. The results suggest that association between spectrin and actin may result in the steric hindrance of reactivity of a limited number of sulphydryl groups in each protein. Disruption of the spectrin-actin association may then be linked to the modification of the sulphydryl groups.
D004910:Erythrocyte Membrane / Q000187:drug effects / Q000648:ultrastructure*; D005033:Ethylmaleimide / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008563:Membrane Lipids / Q000097:blood*; D008565:Membrane Proteins / Q000097:blood*; D009994:Osmolar Concentration; D010663:Phenylmercury Compounds / Q000494:pharmacology*; D012995:Solubility
D008563:Membrane Lipids; D008565:Membrane Proteins; D010663:Phenylmercury Compounds; C031219:4-mercuribenzene sulfonate; D005033:Ethylmaleimide